The average selling price for AZURE in Finland dropped in 2022, according to GlobalData. The average selling price, the complete price range of high and low prices and a 3-year forecast for the AZURE device in Finland can be viewed in GlobalData’s micro pricing report. Buy the report here.
The AZURE is sold by Medtronic Plc in the Dual Chamber Pacemaker market. Dual chamber pacemakers deliver energy to the heart muscle through wires called leads. The leads carry the electric impulse from the pacemaker to the heart and relay information about the heart’s natural activity back to the pacemaker. One lead paces the atrium and one paces the ventricle. This approach more closely mathches the natural pacing of the heart. These types of pacemaker can co-ordinate function between the atria and ventricles.
Factors contributing to the list price of a medical device include but are not limited to therapy area, complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. Moreover, final selling prices vary geographically and by facility type. These prices are further subject to discounts, as well as purchasing and distribution agreements.
For a complete picture of Medtronic Plc’ Dual Chamber Pacemaker device pricing in Finland, buy the report here.